US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Washington Regional’s Walker Heart Institute now offers the Watchman FLX Pro Left Atrial Appendage Closure (LAAC) Device. The ...

Independence Health System’s Westmoreland Hospital announced that its Heart Lung and Vascular Institute specialists ...

People with Afib have a five-times greater risk of stroke than those with normal heart rhythms, according to CHRISTUS. They state the WATCHMAN device is a small device implanted with a minimally ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...